Opko Health (OPK) | Stock Overview & Key Data
Opko Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $19.20 on June 1, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Opko Health
OPK
|
936.60M Small-cap | 8.53% | 26.13% | 12.90% | 5.26% | 10.24% | 7.35% | 0.69% | -59.56% | -85.41% | -58.99% | 256.10% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 7.56% | 4.21% | -5.21% | -16.94% | -18.64% | 22.27% | -5.31% | 9.75% | 222.18% | 684.25% | 1,233.99% |
|
Danaher
DHR
|
126.39B Large-cap | 1.91% | 1.19% | -14.51% | -22.28% | -23.56% | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
|
Genedx Holdings
WGS
|
1.94B Small-cap | 7.46% | -21.79% | -28.40% | -66.92% | -59.84% | -27.00% | 706.05% | 333.97% | 430.51% | 430.51% | 430.51% |
|
CareDx
CDNA
|
1.09B Small-cap | 2.46% | 5.30% | 17.71% | 26.55% | 15.31% | 34.31% | 180.69% | -71.81% | 399.34% | 128.20% | 128.20% |
|
NeoGenomics
NEO
|
1.03B Small-cap | 9.17% | 12.44% | 6.53% | -16.16% | -13.95% | 44.51% | -41.49% | -74.28% | 17.28% | 651.43% | 1,812.73% |
Ownership & Short Interest
Calculate Your Opko Health Investment Returns
Long-Term Investment Performance Analysis
Opko Health stock price in May 2016 was $10.01, A $1,000.00 lump sum investment in Opko Health made 10 years ago would be worth approximately $145.85 today, representing a negative return of -85.41%. This translates to an annualized return (CAGR) of -17.50%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is OPK's 52-week high and low?
- In the last 52 weeks, Opko Health reached a high of $1.60 (on October 7, 2025) and a low of $0.98 (on N/A).
- What is the market cap and P/E ratio for OPK?
- Curious about Opko Health's size and valuation? Its market capitalization stands at 936.60M. When it comes to valuation, the P/E ratio (trailing twelve months) is -4.08, and the forward P/E (looking ahead) is -3.70.
- Does OPK pay dividends? If so, what's the yield?
- As for dividends, Opko Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Opko Health's main competitors or similar companies to consider before investing?
When looking at Opko Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 22.27% -5.31% Danaher
DHR126.39B Healthcare Diagnostics & Research -3.81% -12.18% Genedx Holdings
WGS1.94B Healthcare Diagnostics & Research -27.00% 706.05% CareDx
CDNA1.09B Healthcare Diagnostics & Research 34.31% 180.69% NeoGenomics
NEO1.03B Healthcare Diagnostics & Research 44.51% -41.49% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Opko Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Opko Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -17.14%, the Debt to Equity ratio from the most recent quarter is 31.29, and its Gross Profit Margin stands at 43.13%.
- What is the recent revenue and earnings growth for OPK?
- Looking at Opko Health's growth, its revenue over the trailing twelve months (TTM) was $607M. Compared to the same quarter last year (YoY), quarterly revenue grew by -19.20%, and quarterly earnings saw a YoY growth of -19.16%.
- How much of OPK stock is held by insiders and institutions?
- Wondering who owns Opko Health stock? Company insiders (like executives and directors) hold about 49.35% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 27.03%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.